C. Thomasin, G. Corradin, Y. Men, H. P. Merkle, and B. Gander. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: Importance of polymer degradation and antigen release for immune response. J. Control. Release 41:131-145 (1996).
M. S. Shive and J. M. Anderson. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28:5-24 (1997).
F. Ahsan, I. P. Rivas, M. A. Khan, and A. I. Torres Suarez. Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages. J. Control. Release 79:29-40 (2002).
D. R. Absolom. Opsonins and dysopsonins: an overview. Methods Enzymol. 132:281-318 (1986).
M. E. Norman, P. Williams, and L. Illum. Influence of block copolymers on the adsorption of plasma proteins to microspheres. Biomaterials 14:193-202 (1993).
G. L. Kenausis, J. Voros, D. L. Elbert, N. P. Huang, R. Hofer, L. Ruiz-Taylor, M. Textor, J. A. Hubbell, and N. D. Spencer. Poly(L-lysine)-g-poly(ethylene glycol) layers on metal oxide surfaces: Attachment mechanism and effects of polymer architecture on resistance to protein adsorption. J. Phys. Chem. B. 104:3298-3309 (2000).
G. R. Harper, M. C. Davies, S. S. Davis, T. F. Tadros, D. C. Taylor, M. P. Irving, and J. A. Waters. Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro. Biomaterials 12:695-700 (1991).
R. Gref, M. Luck, P. Quellec, M. Marchand, E. Dellacherie, S. Harnisch, T. Blunk, and R. H. Muller. ‘stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surfaces B: Biointerfaces. 18:301-313 (2000).
F. X. Lacasse, M. C. Filion, N. C. Philipps, E. Escher, J. N. McMullen, and P. Hildgen. Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis. Pharm. Res. 15:312-317 (1998).
L. Illum, L. O. Jacobsen, R. H. Muller, E. Mak, and S. S. Davis. Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. Biomaterials 8:113-117 (1987).
S. E. Dunn, G. A. Coombes, M. C. Garnett, S. S. Davis, M. C. Davies, and L. Illum. In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers. J. Control. Release 44:65-76 (1997).
M. Luck, K. F. Pistel, Y. X. Li, T. Blunk, R. H. Muller, and T. Kissel. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene)-Influence of production method and polymer composition. J. Control. Release 55:107-120 (1998).
M. A. Tracy, K. L. Ward, L. Firouzabadian, Y. Wang, N. Dong, R. Qian, and Y. Zhang. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials 20:1057-1062 (1999).
D. L. Elbert and J. A. Hubbell. Self-assembly and steric stabilization at heterogeneous, biological surfaces using adsorbing block copolymers. Chem. Biol. 5:177-183 (1998).
E. Walter, D. Dreher, M. Kok, L. Thiele, S. G. Kiama, P. Gehr, and H. P. Merkle. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. J. Control. Release 76:149-168 (2001).
E. Walter and H. P. Merkle. Microparticle-mediated transfection of non-phagocytic cells in vitro. J. Drug Target. 10:11-21 (2002).
S. Vandevondele, J. Vörös, M. Textor, and J. A. Hubbell. RGD-grafted poly-L-lysine-graft-(polyethylene glycol) copolymers block nonspecific protein adsorption while promoting cell adhesion. Biotechnol Bioeng. in press (2002)
N. P. Huang, R. Michel, J. Voros, M. Textor, R. Hofer, A. Rossi, D. L. Elbert, J. A. Hubbell, and N. D. Spencer. Poly(L-lysine)-g-poly(ethylene glycol) layers on metal oxide surfaces: Surface-analytical characterization and resistance to serum and fibrinogen adsorption. Langmuir 17:489-498 (2001).
E. Walter, K. Moelling, J. Pavlovic, and H. P. Merkle. Microencapsulation of DNA using poly(DL-lactide-co-glycolide): Stability issues and release characteristics. J. Control. Release 61:361-374 (1999).
F. Sallusto, M. Cella, C. Danieli, and A. Lanzavecchia. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389-400 (1995).
L. Thiele, B. Rothen-Rutishauser, S. Jilek, H. Wunderli-Allenspach, H. P. Merkle, and E. Walter. Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? J. Control. Release 76:59-71 (2001).
L. Cochand, P. Isler, F. Songeon, and L. P. Nicod. Human lung dendritic cells have an immature phenotype with efficient mannose receptors. Am. J. Respir. Cell Mol. Biol. 21:547-554 (1999).
M. L. Albert, B. Sauter, and N. Bhardwaj. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89 (1998).
S. C. Finnemann and E. Rodriguez-Boulan. Macrophage and retinal pigment epithelium phagocytosis: apoptotic cells and photoreceptors compete for alphavbeta3 and alphavbeta5 integrins, and protein kinase C regulates alphavbeta5 binding and cytoskeletal linkage. J. Exp. Med. 190:861-874 (1999).
A. Rubartelli, A. Poggi, and M. R. Zocchi. The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium. Eur. J. Immunol. 27:1893-1900 (1997).
S. M. Moghimi, C. J. H. Porter, I. S. Muir, L. Illum, and S. S. Davis. Non-Phagocytic Uptake of Intravenously Injected Microspheres in Rat Spleen-Influence of Particle-Size and Hydrophilic Coating. Biochem. Biophys. Res. Commun. 177:861-866 (1991).
R. Alyautdin, D. Goethier, V. Petrov, and D. Kharkevich. and J. Kreuter. Analgesic activity of the hexapeptide dlargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles. Eur. J. Pharm. Biopharm. 41:44-48 (1995).
R. H. Muller, S. Maassen, H. Weyhers, and W. Mehnert. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J. Drug Target. 4:161-170 (1996).
J. C. Neal, S. Stolnik, M. C. Garnett, S. S. Davis, and L. Illum. Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres. Pharm. Res. 15:318-324 (1998).
L. Araujo and R. Lobenberg. and J. Kreuter. Influence of the surfactant concentration on the body distribution of nanoparticles. J. Drug Target. 6:373-385 (1999).
H. Takeuchi, H. Kojima, T. Toyoda, H. Yamamoto, T. Hino, and Y. Kawashima. Prolonged circulation time of doxorubicin-loaded liposomes coated with a modified polyvinyl alcohol after intravenous injection in rats. Eur. J. Pharm. Biopharm. 48:123-129 (1999).
A. L. Klibanov. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv. Drug Deliv. Rev. 37:139-157 (1999).
K. Avgoustakis, A. Beletsi, Z. Panagi, P. Klepetsanis, A. G. Karydas, and D. S. Ithakissios. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Control. Release 79:123-135 (2002).
C. S. Cho, K. Y. Cho, I. K. Park, S. H. Kim, T. Sasagawa, M. Uchiyama, and T. Akaike. Receptor-mediated delivery of all trans-retinoic acid to hepatocyte using poly(L-lactic acid) nanoparticles coated with galactose-carrying polystyrene. J. Control. Release 77:7-15 (2001).
J. E. Blackwell, N. M. Dagia, J. B. Dickerson, E. L. Berg, and D. J. Goetz. Ligand coated nanosphere adhesion to E-and P-selectin under static and flow conditions. Ann. Biomed. Eng. 29:523-533 (2001).
S. Rudge, C. Peterson, C. Vessely, J. Koda, S. Stevens, and L. Catterall. Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC). J. Control. Release 74:335-340 (2001).
Y. Maitani, K. Kawano, K. Yamada, T. Nagau, and K. Takayama. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells. J. Control. Release 75:381-389 (2001).
A. Gessner, C. Olbrich, W. Schroder, O. Kayser, and R. H. Muller. The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles. Int. J. Pharm. 214:87-91 (2001).
R. Igarashi, M. Takenaga, J. Takeuchi, A. Kitagawa, K. Matsumoto, and Y. Mizushima. Marked hypotensive and blood flow-increasing effects of a new lipo-PGE(1) (lipo-AS013) due to vascular wall targeting. J. Control. Release 71:157-164 (2001).
C. S. Cho, A. Kobayashi, R. Takei, T. Ishihara, A. Maruyama, and T. Akaike. Receptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymers. Biomaterials 22:45-51 (2001).
M. A. Chattergoon, J. J. Kim, J. S. Yang, T. M. Robinson, D. J. Lee, T. Dentchev, D. M. Wilson, V. Ayyavoo, and D. B. Weiner. Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis. Nat. Biotechol. 18:974-979 (2000).
P. Jeannin, T. Renno, L. Goetsch, I. Miconnet, J. P. Aubry, Y. Delneste, N. Herbault, T. Baussant, G. Magistrelli, C. Soulas, P. Romero, J. C. Cerottini, and J. Y. Bonnefoy. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat. Immunol. 1:502-509 (2000).
Y. Shibata, W. J. Metzger, and Q. N. Myrvik. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production. J. Immunol. 159:2462-2467 (1997).
A. Regnault, D. Lankar, V. Lacabanne, A. Rodriguez, C. Thery, M. Rescigno, T. Saito, S. Verbeek, C. Bonnerot, P. Ricciardi-Castagnoli, and S. Amigorena. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:371-380 (1999).
P. Johansen, Y. Men, H. P. Merkle, and B. Gander. Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination. European Eur. J. Pharm. Biopharm. 50:129-146 (2000).
M. Müller, J. Vörös, G. Csucs, E. Walter, G. Danuser, M. Textor, H. P. Merkle, and N. D. Spencer. Surface modification of PLGA microspheres. J. Biomed. Mat. Res. In press.
A. A. Bogdanov, R. Weissleder, H. W. Frank, A. V. Bogdanova, N. Nossif, B. K. Schaffer, E. Tsau, M. I. Papisov, and T. J. Brady. A new macromolecule as a contrast agent for MR-angiography—preparation, properties, and animal studies. Radiology 187:701-706 (1993).
A. A. Bogdanov, C. Martin, A. V. Bogdanova, T. J. Brady, and R. Weissleder. An adduct of cis-diamminedichloroplatinum(II) and poly(ethylene glycol)poly(L-lysine)-succinate: synthesis and cytotoxic properties. Bioconjugate Chem. 7:144-149 (1996).
H. J. P. Ryser, R. Mandel, A. Hacobian, and W. C. Shen. Methotrexate-poly(lysine) as a selective agent for mutants of chinese-hamster ovary cells defective in endocytosis. J. Cell. Physiol. 135:277-284 (1988).
J. C. Leroux, F. De Jaeghere, B. Anner, E. Doelker, and R. Gurny. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. Life Sci. 57:695-703 (1995).
F. De Jaeghere, E. Allemann, J. Feijen, T. Kissel, E. Doelker, and R. Gurny. Cellular uptake of PEO surface-modified nanoparticles: evaluation of nanoparticles made of PLA:PEO diblock and triblock copolymers. J. Drug Target. 8:143-153 (2000).
T. Verrecchia, G. Spenlehauer, D. V. Bazile, A. Murry-Brelier, Y. Archimbaud, and M. Veillard. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J. Control. Release 36:49-61 (1995).
T. B. Geijtenbeek, D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani, D. R. Littman, C. G. Figdor, and Y. van Kooyk. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-597 (2000).